Novartis Poaches GSK Veteran as New Sandoz CEO

GlaxoSmithKline veteran Richard Saynor is coming home to Sandoz. Saynor was named the new chief executive officer of the Novartis’ subsidiary on Tuesday.

For the past nine years, Saynor has been with GSK, most recently serving as senior vice president and global head of classic and established medicines at the U.K. pharma giant.